Please enable Javascript to get a taste of that Hopium 👼

ATNX - Company Overview - Athenex Inc
Athenex Inc
NASDAQ: atnx

$1.57

USD

+$0.09

+6.08%

Prev Close

$1.48

Today's Open

$1.46

Volume

1.62M

Market Cap

171.63M

Day Range

1.40

range triangle

1.61

52W Range

1.34

range triangle

15.00

Overview

Athenex, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of drugs for the treatment of cancer. The company is headquartered in Buffalo, New York.

Read more
Current Price
15 min delay
Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

-1.45

P/E Ratio

0

Price to Sales

1.429

Price to Book

1.101

Profit Ratios

Profit Margin

-123.80%

EBITDA Margin

-121.87%

Net Profit Margin

41.89%

ROA

-21.00%

Total Revenue

$117.05M

Net Profit

$49.04M

EV to EBITDA

0

EV to Revenue

2.026

Data source(s): Alpha Vantage